Pathstone Family Office’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$25.3M Buy
169,603
+113,959
+205% +$17M 0.19% 82
2023
Q2
$7.1M Buy
55,644
+3,769
+7% +$481K 0.1% 137
2023
Q1
$8.14M Sell
51,875
-114,715
-69% -$18M 0.13% 105
2022
Q4
$24.5M Buy
166,590
+41,550
+33% +$6.12M 0.21% 84
2022
Q3
$16.9M Buy
125,040
+86,483
+224% +$11.7M 0.15% 87
2022
Q2
$5.91M Buy
38,557
+18,605
+93% +$2.85M 0.13% 94
2022
Q1
$3.31M Sell
19,952
-1,454
-7% -$241K 0.08% 125
2021
Q4
$2.9M Buy
21,406
+1,159
+6% +$157K 0.07% 142
2021
Q3
$2.18M Buy
20,247
+736
+4% +$79.4K 0.06% 153
2021
Q2
$2.2M Buy
19,511
+4,709
+32% +$530K 0.07% 151
2021
Q1
$1.6M Buy
14,802
+5,536
+60% +$599K 0.05% 147
2020
Q4
$993K Buy
9,266
+3,837
+71% +$411K 0.04% 121
2020
Q3
$475K Buy
5,429
+89
+2% +$7.79K 0.05% 117
2020
Q2
$526K Buy
5,340
+2,304
+76% +$227K 0.06% 102
2020
Q1
$233K Buy
3,036
+229
+8% +$17.6K 0.03% 154
2019
Q4
$2.49M Buy
2,807
+72
+3% +$63.8K 0.03% 141
2019
Q3
$207K Sell
2,735
-5,429
-66% -$411K 0.03% 142
2019
Q2
$595K Buy
8,164
+1,282
+19% +$93.4K 0.07% 118
2019
Q1
$555K Buy
+6,882
New +$555K 0.07% 108
2018
Q2
Sell
-362
Closed -$34K 151
2018
Q1
$34K Buy
+362
New +$34K 0.02% 126
2017
Q3
Sell
-4,015
Closed -$291K 170
2017
Q2
$291K Sell
4,015
-137
-3% -$9.93K 0.12% 75
2017
Q1
$271K Sell
4,152
-472
-10% -$30.8K 0.15% 76
2016
Q4
$289K Buy
4,624
+4,528
+4,717% +$283K 0.18% 67
2016
Q3
$6K Sell
96
-88
-48% -$5.5K 0.01% 155
2016
Q2
$11K Hold
184
0.01% 127
2016
Q1
$10K Buy
+184
New +$10K 0.02% 113
2015
Q4
Sell
-80
Closed -$4K 83
2015
Q3
$4K Buy
+80
New +$4K 0.01% 128